The co-expression of Crohn’s disease and colon cancer network was analyzed by bioinformatics-CXCL1 tumour microenvironment and prognosis-related gene CXCL1
Purpose This study aimed to investigate the molecular links and mechanisms between Crohn’s disease (CD) and colorectal cancer (CRC). Methods This study used the Gene Expression Omnibus (GEO) database to identify Differentially expressed genes (DEGs) in CD (GSE112366) and CRC (GSE110224), analyzed by...
Gespeichert in:
Veröffentlicht in: | Discover. Oncology 2024-10, Vol.15 (1), p.557-15, Article 557 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
This study aimed to investigate the molecular links and mechanisms between Crohn’s disease (CD) and colorectal cancer (CRC).
Methods
This study used the Gene Expression Omnibus (GEO) database to identify Differentially expressed genes (DEGs) in CD (GSE112366) and CRC (GSE110224), analyzed by 'edgeR' and 'limma'. The Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes explored DEG functions, and the Search Tool for the Retrieval of Interacting Genes (STRING) informed the protein–protein interaction network construction visualized in Cytoscape (version 3.7.2). Cyto-Hubba identified key genes, whose biomarker potential for CD and CRC was evaluated.
Results
The study discovered 61 DEGs, with 44 up- and 17 down-regulated, linked to immune responses and signaling pathways. CXCL1, highly expressed in colon cancer, correlated with better prognosis and lower staging. It also showed associations with immune infiltration and checkpoint molecules, suggesting a role in cancer progression and retreat.
Conclusion
CXCL1 may play a role in the development of colorectal cancer from inflammatory bowel disease. |
---|---|
ISSN: | 2730-6011 2730-6011 |
DOI: | 10.1007/s12672-024-01423-0 |